Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Cleantech Comes of Age

Related Content

The Delaware Question

Why the AI Race Hinges on Elite Talent

ISS Announces Benchmark Policy Update for 2026

OCC Confirms Bank Authority to Hold Certain Crypto-Assets as Principal for Purposes of Paying Crypto-Asset Network Fees

How to Secure and Retain Top Talent in Asset Purchases

SEC’s Division of Corporation Finance Provides Post-Shutdown Guidance

California Air Resources Board Posts Draft Scope 1 and 2 GHG Reporting Template

SEC Chairman Vows to Make IPOs Great Again

Goodwin Advises Arthrosi Therapeutics in Agreement to be Acquired by Sobi for $950 Million Upfront and $550 Million in Milestones

Goodwin Represents Cycle Pharmaceuticals in Acquisition of Applied Therapeutics

Goodwin Highly Ranked in IFLR1000’s 2026 Financial and Corporate Law Rankings

Goodwin Advises Lumine Group on Agreement to Acquire Synchronoss Technologies

Goodwin Expands London Technology M&A Team with the Arrival of Emmie Jones

The Wolves Are Howling: Activist Packs Are Complicating Engagement (Agenda)

Goodwin Advises Avadel Pharmaceuticals on Increased Offer from Alkermes

Goodwin Advises Centerview Partners on Semrush’s $1.9 Billion Acquisition by Adobe

Mergers & Acquisitions